Detail Information
Publications
Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Thomas Grobner
Department of Nephrology, General Hopsital of Wiener Neustadt, A 2700 Wiener Neustadt, Austria
Nephrol Dial Transplant 21:1104-8. 2006
Gadolinium and nephrogenic systemic fibrosisT Grobner
12nd Department of Medicine Nephrology, General Hospital of Wiener Neustadt, Wiener Neustadt, Austria
Kidney Int 72:260-4. 2007..In this short review, the development of NSF and its sequential association with the exposure to gadolinium-containing contrast agents is presented. The mechanisms likely to cause NFD/NSF are discussed...
Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposureThomas Grobner
2nd Department of Medicine Nephrology, General Hospital of Wiener Neustadt, Wiener Neustadt, Austria
Semin Dial 21:135-9. 2008..Other potential risk factors include metabolic acidosis, iron overload/intravenous iron, divalent ion disturbances, endothelial/vascular injury, and high erythropoietin doses. Further studies are required...
Conventional or Gadolinium containing contrast media: the choice between acute renal failure or Nephrogenic Systemic Fibrosis?Alexander R Rosenkranz
Clinical Division of Nephrology, Innsbruck Medical University, Innsbruck, Austria
Wien Klin Wochenschr 119:271-5. 2007
